Clinical Trials Browser

OTHER × Central Nervous System Neoplasms × Interferon alpha-2 × Clear all

NCT00002965 2023-12-22

Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas

Phase 2 Completed

Brain Neoplasms, Central Nervous System Neoplasms